VLA 0.00% $1.75 viralytics limited

Merck takeover $1.75 a share, page-17

  1. 9,595 Posts.
    lightbulb Created with Sketch. 330
    Hi kmsmith,

    I guess it's depends on where you bought. It's almost a six bagger for me. And after the recent share price performance it looks great.

    Whilst vla do have a valuable product (more valuable than this offer, as proved by BristolMS's deal last week) it is an old new technology (if that makes sense). New and exciting things are coming along all the time.

    I kind of had a conflict as I also hold imu, and they have the power to blow CAVATAK away. But saying that, CAVATAK is quite close to being a very profitable product.

    cheers
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.